Literature DB >> 9837889

The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion.

V T Hinkovska-Galcheva1, L A Boxer, P J Mansfield, D Harsh, A Blackwood, J A Shayman.   

Abstract

Ceramide, a product of agonist-stimulated sphingomyelinase activation, is known to be generated during the phagocytosis of antibody-coated erythrocytes by polymorphonuclear leukocytes. Agonist-stimulated formation of ceramide-1-phosphate is now shown to occur in 32PO4-labeled neutrophils. Ceramide-1-phosphate is formed by a calcium-dependent ceramide kinase, found predominately in the neutrophil plasma membrane. The neutrophil kinase is specific for ceramide because, in contrast to the bacterial diglyceride kinase, ceramide is not phosphorylated under conditions specific for diglyceride phosphorylation. Conversely, 1,2-diacylglycerol does not serve as substrate for the neutrophil ceramide kinase. Ceramide kinase activation occurs in a time-dependent fashion, reaching peak activity 10 min after formyl peptide stimulation and challenge with antibody-coated erythrocytes. The lipid kinase activity is optimal at pH 6.8. Because the formation of the phagolysosome is a critical event in phagocytosis, the effect of ceramide-1-phosphate in promoting the fusion of liposomes was determined. Both the addition of increasing concentrations of sphingomyelinase D and ceramide-1-phosphate promoted liposomal fusion. In summary, ceramide-1-phosphate is formed during phagocytosis through activation of ceramide kinase. Ceramide-1-phosphate may promote phagolysosome formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837889     DOI: 10.1074/jbc.273.50.33203

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Lipid targeting domain with dual-membrane specificity that expands the diversity of intracellular targeting reactions.

Authors:  Joseph J Falke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-26       Impact factor: 11.205

2.  A critical beta6-beta7 loop in the pleckstrin homology domain of ceramide kinase.

Authors:  Philipp Rovina; Markus Jaritz; Siegfried Höfinger; Christine Graf; Piroska Dévay; Andreas Billich; Thomas Baumruker; Frédéric Bornancin
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

Review 3.  Lipidomics in translational research and the clinical significance of lipid-based biomarkers.

Authors:  Daniel J Stephenson; L Alexis Hoeferlin; Charles E Chalfant
Journal:  Transl Res       Date:  2017-06-15       Impact factor: 7.012

4.  Ceramide 1-phosphate increases intracellular free calcium concentrations in thyroid FRTL-5 cells: evidence for an effect mediated by inositol 1,4,5-trisphosphate and intracellular sphingosine 1-phosphate.

Authors:  Susanna Högback; Petra Leppimäki; Britt Rudnäs; Sonja Björklund; J Peter Slotte; Kid Törnquist
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

5.  Chain length specificity for activation of cPLA2alpha by C1P: use of the dodecane delivery system to determine lipid-specific effects.

Authors:  Dayanjan S Wijesinghe; Preeti Subramanian; Nadia F Lamour; Luciana B Gentile; Maria H Granado; Alicja Bielawska; Zdzislaw Szulc; Antonio Gomez-Munoz; Charles E Chalfant
Journal:  J Lipid Res       Date:  2008-12-15       Impact factor: 5.922

Review 6.  Glycosphingolipids and cell death.

Authors:  Meryem Bektas; Sarah Spiegel
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 7.  A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity.

Authors:  James A Shayman; Akira Abe; Miki Hiraoka
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 8.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

9.  Ceramides modulate programmed cell death in plants.

Authors:  Hua Liang; Nan Yao; Jong Tae Song; Song Luo; Hua Lu; Jean T Greenberg
Journal:  Genes Dev       Date:  2003-10-16       Impact factor: 11.361

10.  Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1-/- mice.

Authors:  Satoru Niwa; Nicole Urtz; Thomas Baumruker; Andreas Billich; Frédéric Bornancin
Journal:  Lipids Health Dis       Date:  2010-01-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.